Parathyroid hormone increases the expression level of matrix metalloproteinase-13 in vivo.
Parathyroid hormone (PTH) increases serum calcium (Ca) by enhancing bone resorption and renal Ca reabsorption. However, detailed mechanisms of enhanced bone resorption by PTH remain to be elucidated. Although PTH has been shown to increase the expression level of osteoblastic matrix metalloproteinase (MMP)-13 in vitro, only limited results are available regarding the in vivo regulation of MMP expression. In the present study, we have examined expression levels of MMPs in PTH-infused rats. Infusion of 1.5 or 2.0 nmol/kg/day rat PTH(1-34) for 3 days resulted in a dose-dependent increase in serum Ca. PTH infusion also decreased serum phosphate levels and increased urinary excretion of Ca and phosphate. Infusion of PTH for 7 days resulted in less severe hypercalcemia and hypophosphatemia. Urinary Ca and phosphate excretion in rats infused for 7 days was less than that in rats infused for 3 days. Northern blot analysis showed that PTH infusion increased the expression level of MMP-13 in calvaria, although it did not affect MMP-2 expression. Furthermore, the time-course and severity of hypercalcemia and hypercalciuria correlated with the expression level of MMP-13. In situ hybridization also showed that PTH infusion increased the expression level of MMP-13 in femora. These results indicate that PTH enhances MMP-13 expression in vivo and suggest that PTH stimulates bone resorption at least partly by enhancing MMP-13 expression.
Uchida
M
M
Biomedical Research Laboratories, Kureha Chemical Industry Co. Ltd, Tokyo, Japan.
Yamato
H
H
Nagai
Y
Y
Yamagiwa
H
H
Hayami
T
T
Tokunaga
K
K
Endo
N
N
Suzuki
H
H
Obara
K
K
Fujieda
A
A
Murayama
H
H
Fukumoto
S
S
D000818:Animals; D001483:Base Sequence; D001862:Bone Resorption / Q000139:chemically induced / Q000201:enzymology / Q000235:genetics; D001842:Bone and Bones / Q000187:drug effects / Q000201:enzymology; D002118:Calcium / Q000097:blood / Q000652:urine; D017364:Collagenases / Q000235:genetics* / Q000378:metabolism*; D018076:DNA, Complementary / Q000235:genetics; D015870:Gene Expression / Q000187:drug effects; D017403:In Situ Hybridization; D008297:Male; D053509:Matrix Metalloproteinase 13; D020778:Matrix Metalloproteinase 2 / Q000235:genetics / Q000378:metabolism; D010281:Parathyroid Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D010710:Phosphates / Q000097:blood / Q000652:urine; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar
D018076:DNA, Complementary; D010281:Parathyroid Hormone; D010710:Phosphates; D012333:RNA, Messenger; D017364:Collagenases; D053509:Matrix Metalloproteinase 13; C507083:Mmp13 protein, rat; D020778:Matrix Metalloproteinase 2; D002118:Calcium